Skip to content
OpenCapital
Get started

Cross Country Healthcare CCRN Sales allowance, billing-related adjustments

Other financials

Income statement

See full
Revenue$241.1M-17.8%
Operating income-$4.2M-325%
Net income-$4.3M-771%
EPS (diluted)-$0.14-600%

Balance sheet

See full
Cash & equivalents$105.6M+30.8%
Total debt$2.0M-38.3%
Total equity$312.8M-25.2%
Total assets$451.1M-21.7%

Cash flow

See full
Operating cash flow$4.8M-16.1%
CapEx$1.5M-22.7%
Free cash flow$3.3M-12.8%

Valuation

See full
Market cap$426.12M-6.5%
Enterprise value$322.58M-14.7%
P/S0.4×+0.1×

Profitability

See full
Operating margin-8.7%-11.4pp
Net margin-9.8%-11.8pp
FCF margin4%-4.9pp

Returns & leverage

See full
Return on equity-27%-32.7pp
Debt / equity0×0.0×
Current ratio3.3×+0.3×

Where this comes from

Reported directly by Cross Country Healthcare in its filing.

Tagged under the XBRL concept ccrn:SalesAllowanceBillingRelatedAdjustments.

The official record: Cross Country Healthcare’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cross Country Healthcare's sales allowance, billing-related adjustments.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cross Country Healthcare's sales allowance, billing-related adjustments?
Cross Country Healthcare (CCRN) reported sales allowance, billing-related adjustments of $300K in Q1 2026.
How has Cross Country Healthcare's sales allowance, billing-related adjustments changed year-over-year?
Cross Country Healthcare's sales allowance, billing-related adjustments decreased by 25.0% year-over-year, from $400K to $300K.
What is the long-term trend for Cross Country Healthcare's sales allowance, billing-related adjustments?
Over 5 years (2020 to 2025), Cross Country Healthcare's sales allowance, billing-related adjustments has grown at a -12.9% compound annual growth rate (CAGR), from $600K to $300K.